Lixte Biotechnology Holdings, Inc. Share Price
LIXTLixte Biotechnology Holdings, Inc. Stock Performance
Open $4.19 | Prev. Close $4.06 | Circuit Range N/A |
Day Range $4.19 - $4.19 | Year Range $0.64 - $6.14 | Volume 373 |
Average Traded $4.19 |
Lixte Biotechnology Holdings, Inc. Share Price Chart
About Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Lixte Biotechnology Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
02-Dec-25 | $4.00 | $4.04 | -2.42% |
01-Dec-25 | $4.17 | $4.14 | -2.93% |
28-Nov-25 | $4.19 | $4.26 | +6.63% |
26-Nov-25 | $3.99 | $4.00 | -1.72% |
25-Nov-25 | $4.52 | $4.07 | -9.76% |
24-Nov-25 | $4.51 | $4.51 | +3.92% |
21-Nov-25 | $4.40 | $4.34 | +0.70% |
FAQs on Lixte Biotechnology Holdings, Inc. Share Price
Can I buy Lixte Biotechnology Holdings, Inc. shares in India?
What is the share price of Lixte Biotechnology Holdings, Inc.?
What is the 5 year returns of Lixte Biotechnology Holdings, Inc.?
What are the high & low stock price of Lixte Biotechnology Holdings, Inc. today?
What is the 52-week high and low of Lixte Biotechnology Holdings, Inc. stock?